drugset / Trial / NCT04068051

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

NCT04068051

Phase 3 Completed 706 enrolled Axsome Therapeutics, Inc.
NaSingle-groupOpen-labelTreatment

Summary

MOVEMENT (Multimechanistic Treatment over Time of Migraine Symptoms) is a Phase 3 study to evaluate the long-term safety of chronic intermittent use of AXS-07 and to assess the effect of AXS-07 on migraine symptoms following repeated treatment of migraine attacks.

Timeline

Start
2019-07-06
Primary completion
2020-09-22
Completion
2020-09-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule Oral
Subject rizatriptan Unknown Oral

Indications